With nearly half of all pregnancies worldwide being unintended, the need for effective, reversible male contraceptives ...

(Reuters) -Contract research organizations are reporting better-than-expected second-quarter profit, a sign that Wall Street analysts say reflects a rebound in biotech and pharmaceutical spending ...

Relevant biomarkers include cytokines and targets such as IL-4, IgE, IL-5, IL-13, IL-33, and TSLP (Figure 2). A number of targeted drugs are currently available, including lebrikizumab, dupilumab, and ...

Swiss drugmaker Novartis will pay up to $1 billion to U.S. biotech Matchpoint Therapeutics to develop oral drugs for several ...

We expect Incyte Corporation INCY to surpass expectations when it reports second-quarter 2025 earnings on July 29, before the ...

Lupin Pharmaceuticals’ Clomipramine Hydrochloride capsules are used “for the treatment of obsessions and compulsions in ...

Eight essential nutrients make up the suite of B vitamins also known as the B complex. Research at Tufts and elsewhere has ...

Researchers at the National University of Singapore (NUS) have found new applications of magnetic field therapy with ...

Durham-based TruTechnologies has secured a strategic growth investment from LLR Partners to accelerate the expansion of its real-time clinical trial oversight solutions and fuel the next phase of ...

As leaders across the United States consider options to reduce healthcare costs, they must ensure that well-intended reforms ...

Learn how antibody-drug conjugates are advancing therapies for non-cancer conditions, unlocking new possibilities in ...

Loss per share was $(0.58), falling short of analyst expectations by $(0.13), or 29.1% (GAAP, Q2 2025). - Research and development expenses rose to $60.2 million in Q2 2025, up from $23.8 million in ...